Fighting COVID-19
Related Content
COVID-19
CARE Consortium
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Read more
COVID-19
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19
Read more
COVID-19
Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing communiqué with the Gates Foundation.
Read more